Free Trial
NASDAQ:GCTK

GlucoTrack (GCTK) Stock Price, News & Analysis

GlucoTrack logo
$0.25 -0.02 (-7.41%)
(As of 11/21/2024 ET)

About GlucoTrack Stock (NASDAQ:GCTK)

Key Stats

Today's Range
$0.22
$0.26
50-Day Range
$0.25
$2.92
52-Week Range
$0.22
$4.95
Volume
473,605 shs
Average Volume
107,514 shs
Market Capitalization
$1.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GlucoTrack Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
1st Percentile Overall Score

GCTK MarketRank™: 

GlucoTrack scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for GlucoTrack.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of GlucoTrack is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of GlucoTrack is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    1.22% of the float of GlucoTrack has been sold short.
  • Short Interest Ratio / Days to Cover

    GlucoTrack has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GlucoTrack has recently increased by 77.93%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    GlucoTrack does not currently pay a dividend.

  • Dividend Growth

    GlucoTrack does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.22% of the float of GlucoTrack has been sold short.
  • Short Interest Ratio / Days to Cover

    GlucoTrack has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in GlucoTrack has recently increased by 77.93%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for GlucoTrack this week, compared to 0 articles on an average week.
  • Search Interest

    3 people have searched for GCTK on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, GlucoTrack insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.30% of the stock of GlucoTrack is held by insiders.

  • Percentage Held by Institutions

    Only 10.92% of the stock of GlucoTrack is held by institutions.

  • Read more about GlucoTrack's insider trading history.
Receive GCTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlucoTrack and its competitors with MarketBeat's FREE daily newsletter.

GCTK Stock News Headlines

GlucoTrack Completes Funding to Enhance Financial Stability
What Comes Next Could Be a Once-in-a-Lifetime Opportunity
A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
See More Headlines

GCTK Stock Analysis - Frequently Asked Questions

GlucoTrack's stock was trading at $1.3075 at the beginning of the year. Since then, GCTK shares have decreased by 80.9% and is now trading at $0.2499.
View the best growth stocks for 2024 here
.

GlucoTrack shares reverse split on Monday, May 20th 2024. The 1-5 reverse split was announced on Monday, May 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of GCTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that GlucoTrack investors own include Rolls-Royce Holdings plc (RYCEY), Blink Charging (BLNK), Cameco (CCJ), Cybin (CYBN), Cyclo Therapeutics (CYTH), Ford Motor (F) and iShares U.S. Infrastructure ETF (IFRA).

Company Calendar

Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GCTK
Employees
5
Year Founded
N/A

Profitability

Net Income
$-7,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.70) per share

Miscellaneous

Free Float
5,408,000
Market Cap
$1.44 million
Optionable
Not Optionable
Beta
0.16
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:GCTK) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners